IRIS
BRUNO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.988
EU - Europa 3.494
AS - Asia 2.097
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 12
SA - Sud America 6
AF - Africa 4
Totale 10.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.958
CN - Cina 2.047
IE - Irlanda 1.215
UA - Ucraina 566
FI - Finlandia 421
IT - Italia 415
DE - Germania 331
SE - Svezia 248
GB - Regno Unito 145
FR - Francia 81
BE - Belgio 33
CA - Canada 30
IN - India 26
AU - Australia 11
CH - Svizzera 10
EU - Europa 10
IR - Iran 9
NL - Olanda 8
RU - Federazione Russa 6
TR - Turchia 6
RO - Romania 5
MU - Mauritius 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
HK - Hong Kong 3
MD - Moldavia 3
JP - Giappone 2
PL - Polonia 2
SG - Singapore 2
VE - Venezuela 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
NZ - Nuova Zelanda 1
Totale 10.614
Salva come PNG Salva come JPEG
Città #
Dublin 1.214
Chandler 1.181
Jacksonville 722
Nanjing 601
Ashburn 363
Princeton 257
Nanchang 234
Lawrence 224
Wilmington 211
Shenyang 189
Hebei 177
Beijing 175
Changsha 159
Medford 154
Helsinki 146
Jiaxing 128
Ann Arbor 126
Milan 109
New York 85
Tianjin 85
Boardman 82
Hangzhou 81
Shanghai 78
Pavia 66
Woodbridge 55
Norwalk 44
Seattle 43
Verona 39
Los Angeles 32
Brussels 31
Fairfield 31
Houston 28
Pune 24
Toronto 22
Washington 21
Kunming 16
Ningbo 16
San Francisco 14
Zhengzhou 13
Des Moines 12
Auburn Hills 11
Rome 11
Vicenza 11
Jinan 10
Piscataway 10
Berlin 8
Redwood City 8
Taizhou 8
Tappahannock 8
Dearborn 7
London 7
Orange 7
Dallas 6
Guangzhou 6
Varese 6
Zurich 6
Brescia 5
Falls Church 5
Rozzano 5
Canberra 4
Chicago 4
Como 4
Fuzhou 4
Haikou 4
Motta Visconti 4
Sacramento 4
Turin 4
Bergamo 3
Besana in Brianza 3
Campomorone 3
Changchun 3
Chisinau 3
Falkenstein 3
Laives 3
Lanzhou 3
Magenta 3
Melbourne 3
Paceco 3
Weimar 3
Zanjan 3
Acqui Terme 2
Andover 2
Angri 2
Basel 2
Bientina 2
Borås 2
Buccinasco 2
Canyon Country 2
Caracas 2
Corsico 2
Cuggiono 2
Frankfurt am Main 2
Geneva 2
Gunzenhausen 2
Lachine 2
Lecco 2
Liscate 2
Lodi 2
Marcignago 2
Milazzo 2
Totale 7.544
Salva come PNG Salva come JPEG
Nome #
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 225
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 93
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 91
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 90
The Pavia consensus statement 84
Challenges for hepatitis C patients coinfected with HIV. 80
Host factors affecting the outcome of treatment of hepatitis C 78
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 78
Mice and rabbits: Animal models for HIV-1 infection 78
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 73
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 72
Aggressive daily interferon therapy in HIV-HCV coinfected patients 72
Management of hepatitis C in human immunodeficiency virus-infected patients 69
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 67
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 66
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT 66
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 66
Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? 66
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 65
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a 65
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 64
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 63
Malattie Infettive 63
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. 63
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 63
Hepatotoxicity and nelfinavir: a meta-analysis 62
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 62
Ultrasound in the diagnosis of gallbladder ascariasis 62
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 62
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 62
Treatment of echinococcal abdominal cysts 62
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 60
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 60
Reply about: Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis 60
Clinical management of hepatic abscesses in HIV patients 60
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 60
Portal Hypertension in Childhood Bilateral Wilms' Tumor Survivor: An Excellent Indication for TIPS 60
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 60
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 59
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 59
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. 58
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 58
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 58
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 57
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 57
Malattie Infettive 57
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. 57
Transfusion-transmitted virus infection in HIV-1-seropositive patients 57
The Management of Hepatitis B/HIV1 coinfected patients starting their first HAART regimen Treating two infections for the price of one drug?. 57
Effect of the IL-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in HIV co-infected patients 57
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 56
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 56
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 55
Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. 55
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 55
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. 55
Prophylaxis and treatment of hepatitis B in immunocompromised patients 54
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 54
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 54
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 54
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. 54
YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient. 53
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 53
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 53
Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. 53
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 53
Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV coinfected patients 53
Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts 53
Percutaneous drainage of echinococcal cysts (PAIR--puncture, aspiration, injection, reaspiration): results of a worldwide survey for assessment of its safety and efficacy. WHO-Informal Working Group on Echinococcosis-Pair Network 52
Epatite Cronica C: l'ottimizzazione della terapiaCapitolo:efficacia terapeutica , aderenza alla terapia e riduzione di dose in pazienti con epatite cronica C 52
Pathogenesis of liver damage in HCV-HIV patients. 52
Infettivologia e Parassitologia Vol I A-I 52
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 52
Pathogenesis of liver damage in HCV-HIV patients 52
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 52
Endocardite, pericarditee miocardite 51
Epatiti Virali Acute 51
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 51
Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy? 51
The Value of Culture of Pus Via Percutaneous Drainage Under Sonographic Guidance In Diagnosis and Therapy of Pyogenic Liver-abscess 51
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 51
High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus 50
Natural history of chronic hepatitis B in co-infected patients. 50
Infezioni dell’apparatogastrointestinale 50
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 50
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 50
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 50
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 50
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 49
Hepatotoxicity and antiretroviral therapy with protease inhibitors: a review 49
Epatocarcinoma nei soggetti HIV positivi 49
Infettivologia e ParassitologiaVol II J-Z 49
Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles 49
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. 49
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study 49
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 49
Spontaneous hepatitis C virus clearance in HIV-infected patients: new insights for improving management. 48
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. 48
L'Ecografia nella Patologia d'urgenza delle Malattie Infettive 47
Il ruolo della diagnostica Ecografica nelle Malattie Infettive e Tropicali 47
Totale 6.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 0 22 34
2019/20202.449 727 989 23 123 20 138 10 114 7 203 85 10
2020/20211.198 120 93 80 102 15 146 11 198 75 161 149 48
2021/20221.036 33 13 21 11 21 26 23 66 68 15 144 595
2022/20233.398 370 225 39 269 309 347 7 182 1.445 50 100 55
2023/20241.364 155 235 67 81 211 337 80 114 13 59 12 0
Totale 10.944